GNS Healthcare Blog

GNS Healthcare Primary Blog

By December 31, 1969

GNS Healthcare Blog

Population Health to Personalized Medicine: Why Shooting for “Average” Misses the Mark

Current cancer treatments provide benefits to only one out of every four patients. Drugs for Alzheimer’s are ineffective for 70 percent of patients. Medicines for arthritis (50%), diabetes (43%), and asthma (40%) have no benefits for large portions of afflicted individuals. In general, according to a report from the Personalized Medicine Coalition (PMC), many FDA-approved drugs are ineffective on average for nearly half the targeted patient populations.

These sobering statistics are hard to believe in an era of advanced technology, but not so surprising when you get to the core issue....

Read More

3 Ways Causal Machine Learning is Accelerating the Speed of Discovery in Health Care

Imagine if we could approach healthcare with the precision that retailers like Amazon and Netflix use to reach their customers. Imagine if we could grasp the holy grail of precision medicine and harness the ability to match patients with the specific treatment or intervention that is most effective for them as individuals.

How can we scale precision medicine so that every patient is provided with a personally optimized treatment plan? How can we turn data into models of disease progression and drug response, so we can discover novel biomarkers and accelerate drug discovery and development?

Read More

Why Causal Learning is a Superpower for Healthcare

Most people have never heard of causal learning, but the concept is an important one for the future of healthcare because it holds the key to understanding and fighting disease and improving outcomes. However, to understand how and why causality is so important in the fight for better healthcare, we have to first understand machine learning.

You may be familiar with the term “artificial intelligence”, which is a broader umbrella term that machine learning falls within. An article in Xconomy published earlier this year goes into detail on artificial intelligence (AI) and starts by talking...

Read More

Interview with Iya Khalil, Co-founder and CCO of GNS Healthcare

Now it’s time to introduce you to Iya Khalil, who co-founded GNS Healthcare with Colin Hill and serves as the company’s Chief Commercial Officer. When I sat down to talk with Iya, I wanted to get her insights into the company’s work and how it was going to bring its’ industry leading capabilities to more businesses and situations. I also wanted to know more about what the company is doing to identify and fight disease. She was able to help me understand how GNS is working with partners to improve the application of GNS’ solutions and the important work that remains to be accomplished. Now...

Read More

Interview with Colin Hill, CEO and Co-founder of GNS Healthcare

As we’re getting the ball rolling with our new blog, we agreed that there couldn’t be a better way to kick things off than with an interview with GNS Healthcare CEO, Chairman, and co-founder Colin Hill.  So when I had the chance to sit down for a discussion with Colin, what I wanted to know was what was the vision that convinced him to found GNS seventeen years ago and does that mission still hold true today.  What I found is that he has been driven by one seemingly simple question: What needs to be discovered and uncovered to stop disease and its progression?  He’s had a clear vision...

Read More

Welcome to the GNS Healthcare Blog

Our blog will be a forum for discussion – to tackle important issues in precision medicine and focus on how machine learning and artificial intelligence are being applied to improve health outcomes and lower the total cost of care. We’ll discuss topics like healthcare’s matching problem and how big ‘patient’ data can be used to discover which health interventions work for which patients. We’re excited to host this conversation.

While we don’t develop the drugs, or sell the health insurance plans, or treat patients, we work closely with health plans, biopharmaceutical companies, health...

Read More

Subscribe to the GNS Blog

Recent Posts:

Twitter